toxylact: a06ad01 magnesium carbonate

The first professional lActological database in the word

Magnesium carbonate preparations (ATC A06AD01) are generally considered compatible with breastfeeding when used in usual short-term laxative doses, with minimal expected transfer into breast milk and low risk of clinically relevant toxicity in the breastfed infant.e-lactation+1

Pharmacological overview

Magnesium carbonate (ATC A06AD01) is an osmotically acting laxative used for short‑term relief of constipation and difficult defecation. At higher doses it exerts laxative effects through osmotic water retention in the intestinal lumen and stimulation of peristalsis, while in lower doses it may be used as an antacid ingredient. It occurs naturally as a mineral and is also used as a food additive and supplement.medpedia.framar+1

Indications and use in lactating women

The ATC group A06AD comprises osmotically acting laxatives within the “Drugs for constipation” category of the WHO ATC system. Magnesium carbonate within A06AD01 is indicated for constipation, particularly in patients with infrequent stools or difficult defecation. In lactating women, magnesium salts are sometimes used as part of general magnesium supplementation, but for A06AD01 the primary indication remains short‑term treatment of functional constipation rather than chronic supplementation.wikipedia+5

Toxicology profile

Excessive or prolonged intake of magnesium carbonate can lead to systemic magnesium accumulation, especially in patients with renal impairment, with potential depression of the central nervous system and cardiac rhythm disturbances. Local irritant effects have been described at high exposure, including irritation of skin, eyes, and respiratory or gastrointestinal mucosa when inhaled or ingested in large quantities. In overuse, osmotic action may cause diarrhea, electrolyte imbalance, and abdominal cramping; therefore chronic or excessive use is discouraged.wikidoc+2

Lactation safety and infant risk

Available data indicate that ingested magnesium does not significantly concentrate in breast milk, and the physiological magnesium concentration in human milk (mean around 31 mg/L, range 15–64 mg/L) is not appreciably altered by maternal oral magnesium intake. For magnesium carbonate specifically, clinical information on excretion into human milk and direct effects on the breastfed infant remains limited, but magnesium-containing products have been used in breastfeeding women without apparent harmful effects in infants. Expert lactation sources list magnesium carbonate as compatible with breastfeeding, categorized as “not risky” or “moderately safe,” with a recommendation to avoid chronic or excessive dosing and to follow premature or newborn infants more closely because of potentially higher intestinal absorption.drugs+3

Use recommendations during breastfeeding

For lactating women with constipation, short‑term use of magnesium carbonate in standard therapeutic doses is regarded as generally acceptable when the expected maternal benefit outweighs any theoretical infant risk. Clinicians should avoid prolonged high‑dose regimens, particularly in mothers with kidney disease or other conditions predisposing to magnesium retention, and should monitor for maternal adverse effects such as diarrhea, neuromuscular symptoms, or cardiac complaints. Premature or very young infants may have increased intestinal permeability; in such dyads, using the lowest effective maternal dose and considering alternative laxatives with more robust lactation data may be prudent.drugs+4

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.